$Melatonin supplementation improves N‐terminal pro‐B‐type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial$

Melatonin supplementation improves N‐terminal pro‐B‐type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial

Background Melatonin, the major secretion of the pineal gland, has beneficial effects on the cardiovascular system and might advantage heart failure with reduced ejection fraction (HFrEF) by attenuating the effects of the renin–angiotensin–aldosterone and sympathetic system on the heart besides its...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cardiology (Mahwah, N.J.) N.J.), 2022-04, Vol.45 (4), p.417-426
Hauptverfasser:	Hoseini, Shervin G., Heshmat‐Ghahdarijani, Kiyan, Khosrawi, Saeid, Garakyaraghi, Mohammad, Shafie, Davood, Mansourian, Marjan, Roohafza, Hamidreza, Azizi, Elham, Sadeghi, Masoumeh
Format:	Artikel
Sprache:	eng
Schlagworte:	Anxiety brain natriuretic peptide Cardiomyocytes Clinical Investigations Clinical trials Coronaviruses COVID-19 Dietary Supplements Ejection fraction Enzymes Heart failure Heart Failure - diagnosis Heart Failure - drug therapy Humans Intervention Likert scale Melatonin Melatonin - adverse effects Mortality Natriuretic Peptide, Brain Patients Peptide Fragments Peptides Quality of Life Questionnaires Sleep Stroke Volume
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!